Beth M. Forster

A Plaque-Specific Antibody Clears Existing β-amyloid Plaques in Alzheimer's Disease Mice

Ronald B. DeMattos, Jirong Lu, Ying Tang et al. · Neuron · 2012 · 461 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders

Linda M. Rorick‐Kehn, Jeffrey M. Witkin, Michael A. Statnick et al. · Neuropharmacology · 2013 · 153 citations

Medicine, Medicinal Chemistry, Pharmacology +7

Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models

Michael P. Johnson, Mark Muhlhauser, Eric S. Nisenbaum et al. · British Journal of Pharmacology · 2017 · 22 citations · Full text

Medicine, Neuroscience, Pharmacology +17

O4‐04‐02: Identification, characterization, and comparison of amino‐terminally truncated A<i>β</i>₄₂ peptides in Alzheimer's disease brain tissue and in plasma from Alzheimer's patients receiving solanezumab immunotherapy treatment

Ronald B. DeMattos, Margaret M. Racke, Valentina Gelfanova et al. · Alzheimer s & Dementia · 2009 · 15 citations

Life Sciences, Biochemistry, Neuroscience +17